AbCellera Biologics eyes long-term growth with a new facility, clinical trial progress, and a pivot to proprietary drug ...

AI disruption, led by models like Sora, is accelerating and could displace millions of jobs, pressuring the Fed's dual mandate. Learn more about the market here.